These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
567 related articles for article (PubMed ID: 22858219)
1. Neuropsychological and mood effects of ketamine in electroconvulsive therapy: a randomised controlled trial. Loo CK; Katalinic N; Garfield JB; Sainsbury K; Hadzi-Pavlovic D; Mac-Pherson R J Affect Disord; 2012 Dec; 142(1-3):233-40. PubMed ID: 22858219 [TBL] [Abstract][Full Text] [Related]
2. Study protocol for the randomised controlled trial: Ketamine augmentation of ECT to improve outcomes in depression (Ketamine-ECT study). Trevithick L; McAllister-Williams RH; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Ellwell C; Hayden K; Holland F; Karim S; Lowe J; Loo C; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; Anderson IM BMC Psychiatry; 2015 Oct; 15():257. PubMed ID: 26489663 [TBL] [Abstract][Full Text] [Related]
3. Ketamine augmentation of electroconvulsive therapy to improve neuropsychological and clinical outcomes in depression (Ketamine-ECT): a multicentre, double-blind, randomised, parallel-group, superiority trial. Anderson IM; Blamire A; Branton T; Clark R; Downey D; Dunn G; Easton A; Elliott R; Elwell C; Hayden K; Holland F; Karim S; Loo C; Lowe J; Nair R; Oakley T; Prakash A; Sharma PK; Williams SR; McAllister-Williams RH; Lancet Psychiatry; 2017 May; 4(5):365-377. PubMed ID: 28359862 [TBL] [Abstract][Full Text] [Related]
4. Efficacy and cognitive side effects after brief pulse and ultrabrief pulse right unilateral electroconvulsive therapy for major depression: a randomized, double-blind, controlled study. Spaans HP; Verwijk E; Comijs HC; Kok RM; Sienaert P; Bouckaert F; Fannes K; Vandepoel K; Scherder EJ; Stek ML; Kho KH J Clin Psychiatry; 2013 Nov; 74(11):e1029-36. PubMed ID: 24330903 [TBL] [Abstract][Full Text] [Related]
5. Cognitive effects of brief and ultrabrief pulse bitemporal electroconvulsive therapy: a randomised controlled proof-of-concept trial. Martin D; Katalinic N; Hadzi-Pavlovic D; Ingram A; Ingram N; Simpson B; McGoldrick J; Dowling N; Loo C Psychol Med; 2020 May; 50(7):1121-1128. PubMed ID: 31056081 [TBL] [Abstract][Full Text] [Related]
6. Erythropoietin as an add-on treatment for cognitive side effects of electroconvulsive therapy: a study protocol for a randomized controlled trial. Schmidt LS; Petersen JZ; Vinberg M; Hageman I; Olsen NV; Kessing LV; Jørgensen MB; Miskowiak KW Trials; 2018 Apr; 19(1):234. PubMed ID: 29673379 [TBL] [Abstract][Full Text] [Related]
7. Comparing effects of ketamine and thiopental administration during electroconvulsive therapy in patients with major depressive disorder: a randomized, double-blind study. Yoosefi A; Sepehri AS; Kargar M; Akhondzadeh S; Sadeghi M; Rafei A; Alimadadi A; Ghaeli P J ECT; 2014 Mar; 30(1):15-21. PubMed ID: 24091902 [TBL] [Abstract][Full Text] [Related]
8. A randomized controlled trial of brief and ultrabrief pulse right unilateral electroconvulsive therapy. Loo CK; Katalinic N; Smith DJ; Ingram A; Dowling N; Martin D; Addison K; Hadzi-Pavlovic D; Simpson B; Schweitzer I Int J Neuropsychopharmacol; 2014 Dec; 18(1):. PubMed ID: 25522389 [TBL] [Abstract][Full Text] [Related]
9. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance. Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696 [TBL] [Abstract][Full Text] [Related]
10. Effects of pulse width and electrode placement on the efficacy and cognitive effects of electroconvulsive therapy. Sackeim HA; Prudic J; Nobler MS; Fitzsimons L; Lisanby SH; Payne N; Berman RM; Brakemeier EL; Perera T; Devanand DP Brain Stimul; 2008 Apr; 1(2):71-83. PubMed ID: 19756236 [TBL] [Abstract][Full Text] [Related]
11. Memantine in the prevention or alleviation of electroconvulsive therapy induces cognitive disorders: A placebo controlled trial. Abbasinazari M; Adib-Eshgh L; Rostami A; Beyraghi N; Dabir S; Jafari R Asian J Psychiatr; 2015 Jun; 15():5-9. PubMed ID: 25998093 [TBL] [Abstract][Full Text] [Related]
12. Mood and neuropsychological effects of different doses of ketamine in electroconvulsive therapy for treatment-resistant depression. Zhong X; He H; Zhang C; Wang Z; Jiang M; Li Q; Zhang M; Huang X J Affect Disord; 2016 Sep; 201():124-30. PubMed ID: 27208499 [TBL] [Abstract][Full Text] [Related]
13. Ketamine as the anaesthetic for electroconvulsive therapy: the KANECT randomised controlled trial. Fernie G; Currie J; Perrin JS; Stewart CA; Anderson V; Bennett DM; Hay S; Reid IC Br J Psychiatry; 2017 Jun; 210(6):422-428. PubMed ID: 28254962 [No Abstract] [Full Text] [Related]
14. A report on mood and cognitive outcomes with right unilateral ultrabrief pulsewidth (0.3 ms) ECT and retrospective comparison with standard pulsewidth right unilateral ECT. Loo C; Sheehan P; Pigot M; Lyndon W J Affect Disord; 2007 Nov; 103(1-3):277-81. PubMed ID: 17706790 [TBL] [Abstract][Full Text] [Related]
15. Effect of Low Dose of Ketamine on Learning Memory Function in Patients Undergoing Electroconvulsive Therapy-A Randomized, Double-Blind, Controlled Clinical Study. Chen Q; Min S; Hao X; Peng L; Meng H; Luo Q; Chen J; Li X J ECT; 2017 Jun; 33(2):89-95. PubMed ID: 27828927 [TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy of formula-based bifrontal versus right unilateral electroconvulsive therapy (ECT) in the treatment of major depression among elderly patients: a pragmatic, randomized, assessor-blinded, controlled trial. Bjølseth TM; Engedal K; Benth JŠ; Dybedal GS; Gaarden TL; Tanum L J Affect Disord; 2015 Apr; 175():8-17. PubMed ID: 25590761 [TBL] [Abstract][Full Text] [Related]
17. Clinical Outcomes of Magnetic Seizure Therapy vs Electroconvulsive Therapy for Major Depressive Episode: A Randomized Clinical Trial. Deng ZD; Luber B; McClintock SM; Weiner RD; Husain MM; Lisanby SH JAMA Psychiatry; 2024 Mar; 81(3):240-249. PubMed ID: 38055283 [TBL] [Abstract][Full Text] [Related]
18. Clinically favourable effects of ketamine as an anaesthetic for electroconvulsive therapy: a retrospective study. Kranaster L; Kammerer-Ciernioch J; Hoyer C; Sartorius A Eur Arch Psychiatry Clin Neurosci; 2011 Dec; 261(8):575-82. PubMed ID: 21400226 [TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy. Matthews JD; Siefert CJ; Blais MA; Park LT; Siefert CJ; Welch CA; Dubois CM; van Nieuwenhuizen AO; Rooney KO; Seabrook RC; Durham LE; Adams HC; Fava M J ECT; 2013 Sep; 29(3):170-8. PubMed ID: 23519225 [TBL] [Abstract][Full Text] [Related]
20. Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting. Abdallah CG; Fasula M; Kelmendi B; Sanacora G; Ostroff R J ECT; 2012 Sep; 28(3):157-61. PubMed ID: 22847373 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]